70978-37-9

Basic information

• Product Name: 4-Methoxybenzyl azide
• Synonyms: Benzene, 1-(azidomethyl)-4-methoxy-
• CAS NO: 70978-37-9
• Molecular Formula: C₈H₉N₃O
• Molecular Weight: 163.17656
• Mol File: 70978-37-9.mol
• Article Data: 159

Chemical Properties

• Melting Point: 70-71℃
• Boiling Point: 126 °C(Press: 14 Torr)
• Appearance: /
• Density: 1.063 g/cm3 (420 ºC)
• Refractive Index: 1.5272 (589.3 nm 20℃)
• CAS DataBase Reference: 4-Methoxybenzyl azide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Methoxybenzyl azide(70978-37-9)
• EPA Substance Registry System: 4-Methoxybenzyl azide(70978-37-9)

Safety Data

• Hazardous Substances Data: 70978-37-9(Hazardous Substances Data)

Usage

General Description

4-Methoxybenzyl azide is a chemical compound with the molecular formula C8H9N3O. It is an organic compound with a methoxy group (-OCH3) attached to a benzene ring and an azide functional group (-N3). 4-Methoxybenzyl azide is commonly used in organic synthesis as a reagent for the introduction of azide groups into molecules. It is also used in the preparation of pharmaceuticals, agrochemicals, and other organic compounds. 4-Methoxybenzyl azide is known for its potential as a precursor in click chemistry reactions to produce diverse chemical compounds. Additionally, 4-Methoxybenzyl azide plays a crucial role as a building block in the production of compounds used in the pharmaceutical and material science industries.

Upstream product

• 70887-29-5 4-methoxybenzyl iodide 
• 4648-54-8 trimethylsilylazide 
• 2746-25-0 p-Methoxybenzyl bromide 
• 824-94-2 p-methoxybenzyl chloride 
• 623-05-2 (4-hydroxyphenyl)methanol 
• 104-93-8 p-methylanizole 
• 100-66-3 methoxybenzene 
• 92567-07-2 1-(diazidomethyl)-4-methoxybenzene 
• 123-11-5 4-methoxy-benzaldehyde 
• 104-21-2 p-methoxybenzyl acetate 
• 90673-97-5 methanesulfonic acid 4-methoxybenzyl ester 
• 2393-23-9 4-methoxy-benzylamine 
• 18494-82-1 2-(4-methoxy-benzyloxy)-tetrahydro-pyran 
• 105-13-5 4-Methoxybenzyl alcohol 

Downstream Products

• 3261-60-7 N-(4-methoxybenzylidene)-4-methoxybenzylamine 
• 942060-21-1 1-(4-methoxybenzyl)-5-methyl-1H-[1,2,3]triazole-4-carboxylic acid ethyl ester 
• 942060-22-2 3-(4-methoxy-benzyl)-5-methyl-3H-[1,2,3]triazole-4-carboxylic acid ethyl ester 
• 942060-31-3 ethyl 1-(4-methoxybenzyl)-5-(trifluoromethyl)-1H-1,2,3-triazole-4-carboxylate 
• 942060-32-4 ethyl 1-(4-methoxybenzyl)-4-(trifluoromethyl)-1H-1,2,3-triazole-5-carboxylate 
• 1026805-54-8 4-methoxy-1-(4-ferrocenyl-1,2,3-triazol-1-ylmethyl)benzene 
• 874-90-8 4-methoxybenzonitrile 
• 1245773-33-4 (2R,3R,4R,5R)-2-(acetoxymethyl)-5-(6-(1-(4-methoxybenzyl)-1H-1,2,3-triazol-4-yl)-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate 
• 916888-35-2 (5R)-3-[2-Fluoro-4'-({[1-(4-methoxy-benzyl)-1H-[1,2,3]triazol-4-ylmethyl]-amino}-methyl)-biphenyl-4-yl]-5-[1,2,3]triazol-1-ylmethyl-oxazolidin-2-one 
• 916888-36-3 C₃₀H₂₉FN₈O₃ 
• 916888-27-2 C₃₃H₃₇FN₈O₃Si*ClH 
• 916888-26-1 (5R)-3-[2-fluoro-4'-({[1-(4-methoxy-benzyl)-1H-[1,2,3]triazol-4-ylmethyl]-amino}-methyl)-biphenyl-4-yl]-5-(4-trimethylsilanyl-[1,2,3]triazol-1-ylmethyl)-oxazolidin-2-one hydrochloride 
• 916888-15-8 C-[1-(4-methoxybenzyl)-1H-[1,2,3]triazol-4-yl]methylamine 
• 916888-16-9 C-[3-(4-methoxybenzyl)-3H-[1,2,3]triazol-4-yl]-methylamine 

Relevant articles and documents

Regioselectivity in the 1,3-dipolar cycloaddition reactions of nitrile oxides and organic azides with bromocarbazole-1,4-diones

The effect exerted by the presence of a bromine atom in 2 or 3 position of a carbazole-1,4-dione on the regiocontrol of 1,3-dipolar cycloaddition reactions with nitrile oxides and organic azides was investigated. Comparison with the results obtained with

Design and synthesis of novel diosgenin-triazole hybrids targeting inflammation as potential neuroprotective agents

Alzheimer's disease is a progressive neurodegenerative disease, and its incidence is expected to increase as the global population ages. Recent studies provide increasing evidence that inflammation plays a key role in the pathogenesis and progression of AD. Diosgenin, an active ingredient in Dioscorea nipponica Makino, is a promising bioactive lead compound in the treatment of Alzheimer's disease, which exhibited anti-inflammatory activity. To search for more efficient anti-Alzheimer agents, a series of novel diosgenin-triazolyl hybrids were designed, synthesized, and their neuroprotective effects against oxygen-glucose deprivation-induced neurotoxicity and LPS-induced NO production were evaluated. Most of these new hybrids displayed better activities than DIO. In particular, the promising compound L6 not only demonstrated an excellent neuroprotective effect but also showed the best anti-inflammatory activity. The structure-activity relationship study illustrated that the introduction of benzyl or phenyl triazole did improve the activity, and the introduction of benzyl triazole was better than that of phenyl triazole. The results we obtained showed that the diosgenin skeleton could be a promising structural template for the development of new anti-Alzheimer drug candidates, and compound L6 has the potential to be an important lead compound for further research.

COMPOUNDS AND METHODS FOR TREATING OXALATE-RELATED DISEASES

Disclosed herein are compounds and compositions for modulating glycolate oxidase, useful for treating oxalate-related diseases, such as hyperoxaluria, where modulating glycolate oxidase is expected to be therapeutic to a patent in need thereof. Methods of modulating glycolate oxidase activity in a human or animal subject are also provided.